2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium

Wednesday, May 21, 2025 | 8:00 a.m. – 5:00 p.m.
HSCM-MDS_2025_PSTR_Final.pdf

Additional dates:

Next Event: May 22, 2025 8:30 a.m. - 4:30 p.m.

Myelodysplastic Syndromes (MDS) continue to pose significant challenges in hematologic oncology. Advancing treatment strategies for MDS hinges on a deeper understanding of the biological mechanisms governing hematopoietic stem cell function in both normal and stress conditions. To address this, the upcoming MDS symposium aims to bring together global experts specializing in hematopoiesis and MDS. This collaborative effort seeks to facilitate knowledge exchange, foster new insights, and drive forward molecular and therapeutic discoveries in the field of MDS. By convening leaders worldwide, the symposium aims to catalyze progress in understanding and treating this complex blood cancer.